Pages that link to "Item:Q421539"
From MaRDI portal
The following pages link to Evaluating pharmaceutical R\&D under technical and economic uncertainty (Q421539):
Displaying 32 items.
- Optimal investment in research and development under uncertainty (Q255103) (← links)
- A geometric Lévy model for \(n\)-fold compound option pricing in a fuzzy framework (Q289315) (← links)
- Venture capital, staged financing and optimal funding policies under uncertainty (Q322450) (← links)
- Valuation of \(N\)-stage investments under jump-diffusion processes (Q429535) (← links)
- Statistical properties and economic implications of jump-diffusion processes with shot-noise effects (Q635177) (← links)
- Valuing multistage investment projects in the pharmaceutical industry (Q724168) (← links)
- Real options and intellectual property. Capital budgeting under imperfect patent protection. (Q863110) (← links)
- European option based R\&D investment decision making under uncertainties (Q1664669) (← links)
- Patent valuation under spatial point processes with delayed and decreasing jump intensity (Q1675021) (← links)
- Analytical solution for an investment problem under uncertainties with shocks (Q1751925) (← links)
- A real options game of alliance timing decisions in biopharmaceutical research and development (Q1753672) (← links)
- A stochastic model with interacting managerial operating options and debt rescheduling (Q1754234) (← links)
- Real options in operations research: a review (Q1754719) (← links)
- Risky choices in strategic environments: an experimental investigation of a real options game (Q2001463) (← links)
- A real options based decision support tool for R\&D investment: application to CO\(_2\) recycling technology (Q2029058) (← links)
- A model of investment under uncertainty with time to build, market incompleteness and risk aversion (Q2030369) (← links)
- Optimal product release time for a new high-tech startup firm under technical uncertainty (Q2083375) (← links)
- To expand and to abandon: real options under asset variance risk premium (Q2116895) (← links)
- Investment timing and capacity choice in duopolistic competition under a jump-diffusion model (Q2120595) (← links)
- Valuing portfolios of interdependent real options under exogenous and endogenous uncertainties (Q2183319) (← links)
- Valuation of R\&D compound option using Markov chain approach (Q2240681) (← links)
- Quasi-analytical solution of an investment problem with decreasing investment cost due to technological innovations (Q2246762) (← links)
- Compulsory licenses in the pharmaceutical industry: pricing and R\&D strategies (Q2286895) (← links)
- Stochastic competitive entries and dynamic pricing (Q2356104) (← links)
- Staged venture capital investment considering unexpected major events (Q2398792) (← links)
- A simple method for generalized sequential compound options pricing (Q2406942) (← links)
- A model of R\&D valuation and the design of research incentives (Q2518538) (← links)
- Multi-stage real option evaluation with double barrier under stochastic volatility and interest rate (Q2672922) (← links)
- REAL OPTIONS AND THE EVALUATION OF RESEARCH AND DEVELOPEMENT PROJECTS IN THE PHARMACEUTICAL INDUSTRY : A CASE STUDY(Special Issue on Theory, Methodology and Applications in Financial Engneering) (Q4803740) (← links)
- Supporting Innovation in Early-Stage Pharmaceutical Development Decisions (Q5872421) (← links)
- <i>N</i>-Fold compound option pricing with technical risk under fractional jump-diffusion model (Q5882833) (← links)
- Optimal R\&D investment problem with regime-switching (Q6608758) (← links)